Investing Profile

Bali Muralidhar

InvestorVC

Managing Partner at Abingworth

Photo of Bali Muralidhar, Managing Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Abingworth Managing Partner
$100K - $5.0M
$1.5M
9
CompanyStageDateRound SizeTotal Raised
Anjarium Biosciences
Series ASep 2021CHF55.5M
C55.5M
CymaBay Therapeutics
Post-IPO DebtAug 2021$100M
$140.6M
Co-investors: Tony Evnin (Venrock)
Wugen
Series BJul 2021$172M
$172M
Co-investors: John McKearn (RiverVest)
Glycomine
Series BJun 2021$35M
$35M
Co-investors: Jim Trenkle (Sanofi Ventures), Niall O’Donnell (RiverVest)
Reneo Pharmaceuticals
Series BDec 2020$95M
$145M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)
NuCana BioMed
Post-IPO EquityOct 2020$80M
$137M
Co-investors: James Healy (Sofinnova Investments)
Spruce Biosciences
Series BFeb 2020$88M
$88M
Onbone
Venture RoundApr 2015€10M
€10M